|
1
|
Zoon CK, Starker EQ, Wilson AM,
Emmert-Buck MR, Libutti SK and Tangrea MA: Current molecular
diagnostics of breast cancer and the potential incorporation of
microRNA. Expert Rev Mol Diagn. 9:455–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson AB and O’Malley BW: Steroid
receptor coactivators 1, 2, and 3: critical regulators of nuclear
receptor activity and steroid receptor modulator (SRM)-based cancer
therapy. Mol Cell Endocrinol. 348:430–439. 2012. View Article : Google Scholar
|
|
3
|
Jeyapalan Z, Deng Z, Shatseva T, Fang L,
He C and Yang BB: Expression of CD44 3′-untranslated region
regulates endogenous microRNA functions in tumorigenesis and
angiogenesis. Nucleic Acids Res. 39:3026–3041. 2011.
|
|
4
|
Piva R, Spandidos DA and Gambari R: From
microRNA functions to microRNA therapeutics: novel targets and
novel drugs in breast cancer research and treatment (Review). Int J
Oncol. 43:985–994. 2013.PubMed/NCBI
|
|
5
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farazi TA, Horlings HM, Ten Hoeve JJ, et
al: MicroRNA sequence and expression analysis in breast tumors by
deep sequencing. Cancer Res. 71:4443–4453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Andorfer CA, Necela BM, Thompson EA and
Perez EA: MicroRNA signatures: clinical biomarkers for the
diagnosis and treatment of breast cancer. Trends Mol Med.
17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Melo SA and Esteller M: Dysregulation of
microRNAs in cancer: playing with fire. FEBS Lett. 585:2087–2099.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nimmo RA and Slack FJ: An elegant miRror:
microRNAs in stem cells, developmental timing and cancer.
Chromosoma. 118:405–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Wan G, Mlotshwa S, et al:
Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage
signaling pathway. Cancer Res. 70:7176–7186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu F, Jiao Y, Zhu Y, et al: MicroRNA 34c
gene down-regulation via DNA methylation promotes self-renewal and
epithelial-mesenchymal transition in breast tumor-initiating cells.
J Biol Chem. 287:465–473. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimono Y, Zabala M, Cho RW, et al:
Downregulation of miRNA-200c links breast cancer stem cells with
normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greene SB, Herschkowitz JI and Rosen JM:
Small players with big roles: microRNAs as targets to inhibit
breast cancer progression. Curr Drug Targets. 11:1059–1073. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu F, Deng H, Yao H, Liu Q, Su F and Song
E: Mir-30 reduction maintains self-renewal and inhibits apoptosis
in breast tumor-initiating cells. Oncogene. 29:4194–4204. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rubin R, Arzumanyan A, Soliera AR, Ross B,
Peruzzi F and Prisco M: Insulin receptor substrate (IRS)-1
regulates murine embryonic stem (mES) cells self-renewal. J Cell
Physiol. 213:445–453. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang CJ, Chao CH, Xia W, et al: p53
regulates epithelial-mesenchymal transition and stem cell
properties through modulating miRNAs. Nat Cell Biol. 13:317–323.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ahmad A, Aboukameel A, Kong D, et al:
Phosphoglucose isomerase/autocrine motility factor mediates
epithelial-mesenchymal transition regulated by miR-200 in breast
cancer cells. Cancer Res. 71:3400–3409. 2011. View Article : Google Scholar
|
|
18
|
Smith AL, Iwanaga R, Drasin DJ, et al: The
miR-106b-25 cluster targets Smad7, activates TGF-beta signaling,
and induces EMT and tumor initiating cell characteristics
downstream of Six1 in human breast cancer. Oncogene. 31:5162–5171.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng CW, Wang HW, Chang CW, et al:
MicroRNA-30a inhibits cell migration and invasion by downregulating
vimentin expression and is a potential prognostic marker in breast
cancer. Breast Cancer Res Treat. 134:1081–1093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bockhorn J, Yee K, Chang YF, et al:
MicroRNA-30c targets cytoskeleton genes involved in breast cancer
cell invasion. Breast Cancer Res Treat. 137:373–382. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Zhang Y, Zhang W, et al: Genetic
heterogeneity of breast cancer metastasis may be related to miR-21
regulation of TIMP-3 in translation. Int J Surg Oncol.
2013:8750782013.PubMed/NCBI
|
|
25
|
Guttilla IK and White BA: Coordinate
regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast
cancer cells. J Biol Chem. 284:23204–23216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ovcharenko D, Kelnar K, Johnson C, Leng N
and Brown D: Genome-scale microRNA and small interfering RNA
screens identify small RNA modulators of TRAIL-induced apoptosis
pathway. Cancer Res. 67:10782–10788. 2007. View Article : Google Scholar
|
|
27
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu Z, Wang C, Wang M, et al: A cyclin
D1/microRNA 17/20 regulatory feedback loop in control of breast
cancer cell proliferation. J Cell Biol. 182:509–517. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsuchiya Y, Nakajima M, Takagi S, Taniya T
and Yokoi T: MicroRNA regulates the expression of human cytochrome
P450 1B1. Cancer Res. 66:9090–9098. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang S, Huang J, Lyu H, et al: Functional
cooperation of miR-125a, miR-125b, and miR-205 in
entinostat-induced downregulation of erbB2/erbB3 and apoptosis in
breast cancer cells. Cell Death Dis. 4:e5562013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu H and Mo YY: Targeting miR-205 in
breast cancer. Expert Opin Ther Targets. 13:1439–1448. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Spizzo R, Nicoloso MS, Lupini L, et al:
miR-145 participates with TP53 in a death-promoting regulatory loop
and targets estrogen receptor-alpha in human breast cancer cells.
Cell Death Differ. 17:246–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang S, Bian C, Yang Z, et al: miR-145
inhibits breast cancer cell growth through RTKN. Int J Oncol.
34:1461–1466. 2009.PubMed/NCBI
|
|
34
|
Xiong J, Yu D, Wei N, et al: An estrogen
receptor alpha suppressor, microRNA-22, is downregulated in
estrogen receptor alpha-positive human breast cancer cell lines and
clinical samples. FEBS J. 277:1684–1694. 2010. View Article : Google Scholar
|
|
35
|
Adams BD, Furneaux H and White BA: The
micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen
receptor-alpha (ERalpha) and represses ERalpha messenger RNA and
protein expression in breast cancer cell lines. Mol Endocrinol.
21:1132–1147. 2007. View Article : Google Scholar
|
|
36
|
de Souza Rocha Simonini P, Breiling A,
Gupta N, et al: Epigenetically deregulated microRNA-375 is involved
in a positive feedback loop with estrogen receptor alpha in breast
cancer cells. Cancer Res. 70:9175–9184. 2010.
|
|
37
|
Rather MI, Nagashri MN, Swamy SS, Gopinath
KS and Kumar A: Oncogenic microRNA-155 down-regulates tumor
suppressor CDC73 and promotes oral squamous cell carcinoma cell
proliferation: implications for cancer therapeutics. J Biol Chem.
288:608–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu XX, Li XJ, Zhang B, et al:
MicroRNA-26b is underexpressed in human breast cancer and induces
cell apoptosis by targeting SLC7A11. FEBS Lett. 585:1363–1367.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Heyn H, Engelmann M, Schreek S, et al:
MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in
breast cancer development. Int J Cancer. 129:2797–2806. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pellegrino L, Stebbing J, Braga VM, et al:
miR-23b regulates cytoskeletal remodeling, motility and metastasis
by directly targeting multiple transcripts. Nucleic Acids Res.
41:5400–5412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Valastyan S, Chang A, Benaich N, Reinhardt
F and Weinberg RA: Activation of miR-31 function in
already-established metastases elicits metastatic regression. Genes
Dev. 25:646–659. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sossey-Alaoui K, Downs-Kelly E, Das M,
Izem L, Tubbs R and Plow EF: WAVE3, an actin remodeling protein, is
regulated by the metastasis suppressor microRNA, miR-31, during the
invasion-metastasis cascade. Int J Cancer. 129:1331–1343. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Korner C, Keklikoglou I, Bender C, Worner
A, Munstermann E and Wiemann S: MicroRNA-31 sensitizes human breast
cells to apoptosis by direct targeting of protein kinase C epsilon
(PKCepsilon). J Biol Chem. 288:8750–8761. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sachdeva M and Mo YY: MicroRNA-145
suppresses cell invasion and metastasis by directly targeting mucin
1. Cancer Res. 70:378–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hurst DR, Edmonds MD, Scott GK, Benz CC,
Vaidya KS and Welch DR: Breast cancer metastasis suppressor 1
up-regulates miR-146, which suppresses breast cancer metastasis.
Cancer Res. 69:1279–1283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bhaumik D, Scott GK, Schokrpur S, Patil
CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses
NF-kappaB activity with reduction of metastatic potential in breast
cancer cells. Oncogene. 27:5643–5647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Korpal M, Ell BJ, Buffa FM, et al: Direct
targeting of Sec23a by miR-200s influences cancer cell secretome
and promotes metastatic colonization. Nat Med. 17:1101–1108. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Uhlmann S, Zhang JD, Schwäger A, et al:
miR-200bc/429 cluster targets PLCgamma1 and differentially
regulates proliferation and EGF-driven invasion than miR-200a/141
in breast cancer. Oncogene. 29:4297–4306. 2010. View Article : Google Scholar
|
|
50
|
Eades G, Yao Y, Yang M, Zhang Y, Chumsri S
and Zhou Q: miR-200a regulates SIRT1 expression and epithelial to
mesenchymal transition (EMT)-like transformation in mammary
epithelial cells. J Biol Chem. 286:25992–26002. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jurmeister S, Baumann M, Balwierz A, et
al: MicroRNA-200c represses migration and invasion of breast cancer
cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol
Cell Biol. 32:633–651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ding X, Park SI, McCauley LK and Wang CY:
Signaling between transforming growth factor beta (TGF-beta) and
transcription factor SNAI2 represses expression of microRNA miR-203
to promote epithelial-mesenchymal transition and tumor metastasis.
J Biol Chem. 288:10241–10253. 2013. View Article : Google Scholar
|
|
53
|
Tavazoie SF, Alarcón C, Oskarsson T, et
al: Endogenous human microRNAs that suppress breast cancer
metastasis. Nature. 451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu H, Cao YD, Ye WX and Sun YY: Effect of
microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in
MDA-MB-231 cells. Tumori. 96:751–755. 2010.PubMed/NCBI
|
|
55
|
Zhu S, Sachdeva M, Wu F, Lu Z and Mo YY:
Ubc9 promotes breast cell invasion and metastasis in a
sumoylation-independent manner. Oncogene. 29:1763–1772. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hu X, Guo J, Zheng L, et al: The
heterochronic microRNA let-7 inhibits cell motility by regulating
the genes in the actin cytoskeleton pathway in breast cancer. Mol
Cancer Res. 11:240–250. 2013. View Article : Google Scholar
|
|
57
|
Yu Z, Willmarth NE, Zhou J, et al:
microRNA 17/20 inhibits cellular invasion and tumor metastasis in
breast cancer by heterotypic signaling. Proc Natl Acad Sci USA.
107:8231–8236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
59
|
Haque I, Banerjee S, Mehta S, et al:
Cysteine-rich 61-connective tissue growth
factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced
signaling protein-2 (WISP-2) regulates microRNA-10b via
hypoxia-inducible factor-1alpha-TWIST signaling networks in human
breast cancer cells. J Biol Chem. 286:43475–43485. 2011. View Article : Google Scholar
|
|
60
|
Moriarty CH, Pursell B and Mercurio AM:
miR-10b targets Tiam1: implications for Rac activation and
carcinoma migration. J Biol Chem. 285:20541–20546. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Taylor MA, Sossey-Alaoui K, Thompson CL,
Danielpour D and Schiemann WP: TGF-beta upregulates miR-181a
expression to promote breast cancer metastasis. J Clin Invest.
123:150–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lei R, Tang J, Zhuang X, et al:
Suppression of MIM by microRNA-182 activates RhoA and promotes
breast cancer metastasis. Oncogene. 33:1287–1296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Huang Q, Gumireddy K, Schrier M, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yu Z, Baserga R, Chen L, Wang C, Lisanti
MP and Pestell RG: microRNA, cell cycle, and human breast cancer.
Am J Pathol. 176:1058–1064. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zhu N, Zhang D, Xie H, et al:
Endothelial-specific intron-derived miR-126 is down-regulated in
human breast cancer and targets both VEGFA and PIK3R2. Mol Cell
Biochem. 351:157–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Png KJ, Halberg N, Yoshida M and Tavazoie
SF: A microRNA regulon that mediates endothelial recruitment and
metastasis by cancer cells. Nature. 481:190–194. 2012. View Article : Google Scholar
|
|
67
|
Cascio S, D’Andrea A, Ferla R, et al:
miR-20b modulates VEGF expression by targeting HIF-1 alpha and
STAT3 in MCF-7 breast cancer cells. J Cell Physiol. 224:242–249.
2010.PubMed/NCBI
|
|
68
|
Plummer PN, Freeman R, Taft RJ, et al:
MicroRNAs regulate tumor angiogenesis modulated by endothelial
progenitor cells. Cancer Res. 73:341–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Mertens-Talcott SU, Chintharlapalli S, Li
X and Safe S: The oncogenic microRNA-27a targets genes that
regulate specificity protein transcription factors and the G2-M
checkpoint in MDA-MB-231 breast cancer cells. Cancer Res.
67:11001–11011. 2007. View Article : Google Scholar
|
|
70
|
Zhang X, Yu H, Lou JR, et al: MicroRNA-19
(miR-19) regulates tissue factor expression in breast cancer cells.
J Biol Chem. 286:1429–1435. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Wang F, Zheng Z, Guo J and Ding X:
Correlation and quantitation of microRNA aberrant expression in
tissues and sera from patients with breast tumor. Gynecol Oncol.
119:586–593. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Iyevleva AG, Kuligina E, Mitiushkina NV,
Togo AV, Miki Y and Imyanitov EN: High level of miR-21, miR-10b,
and miR-31 expression in bilateral vs. unilateral breast
carcinomas. Breast Cancer Res Treat. 131:1049–1059. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen WX, Hu Q, Qiu MT, et al: miR-221/222:
promising biomarkers for breast cancer. Tumour Biol. 34:1361–1370.
2013. View Article : Google Scholar
|
|
74
|
Buffa FM, Camps C, Winchester L, et al:
microRNA-associated progression pathways and potential therapeutic
targets identified by integrated mRNA and microRNA expression
profiling in breast cancer. Cancer Res. 71:5635–5645. 2011.
View Article : Google Scholar
|
|
75
|
Barh D, Malhotra R, Ravi B and Sindhurani
P: MicroRNA let-7: an emerging next-generation cancer therapeutic.
Curr Oncol. 17:70–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Kim SJ, Oh JS, Shin JY, et al: Development
of microRNA-145 for therapeutic application in breast cancer. J
Control Release. 155:427–434. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Kong W, He L, Coppola M, et al:
MicroRNA-155 regulates cell survival, growth, and chemosensitivity
by targeting FOXO3a in breast cancer. J Biol Chem. 285:17869–17879.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hu H, Li S, Cui X, et al: The
overexpression of hypomethylated miR-663 induces chemotherapy
resistance in human breast cancer cells by targeting heparin
sulfate proteoglycan 2 (HSPG2). J Biol Chem. 288:10973–10985. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liang Z, Wu H, Xia J, et al: Involvement
of miR-326 in chemotherapy resistance of breast cancer through
modulating expression of multidrug resistance-associated protein 1.
Biochem Pharmacol. 79:817–824. 2010. View Article : Google Scholar
|
|
80
|
Pan YZ, Morris ME and Yu AM: MicroRNA-328
negatively regulates the expression of breast cancer resistance
protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol.
75:1374–1379. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Kovalchuk O, Filkowski J, Meservy J, et
al: Involvement of microRNA-451 in resistance of the MCF-7 breast
cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther.
7:2152–2159. 2008. View Article : Google Scholar : PubMed/NCBI
|
